Thompson Siegel & Walmsley’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6
Closed -$1K 802
2021
Q1
$1K Buy
+6
New +$608 ﹤0.01% 742
2019
Q3
Sell
-280
Closed -$23K 770
2019
Q2
$23K Buy
+280
New +$22.3K ﹤0.01% 573
2014
Q2
Sell
-21,600
Closed -$787K 695
2014
Q1
$787K Sell
21,600
-12,100
-36% -$441K 0.02% 293
2013
Q4
$1.17M Sell
33,700
-50
-0.1% -$1.61K 0.03% 277
2013
Q3
$943K Sell
33,750
-800
-2% -$21.3K 0.02% 283
2013
Q2
$931K Buy
+34,550
New +$954K 0.02% 289

Other funds holding XYL

Thompson Siegel & Walmsley's XYL Position: Q2 2021 in Review

Thompson Siegel & Walmsley sold out of Xylem (XYL) in Q2 2021, closing a stake of 6 shares — an estimated $1K sold.

Thompson Siegel & Walmsley first reported a position in XYL in Q2 2013 and held it in 6 quarters. The position peaked at $1.17M in Q4 2013. 773 funds tracked by Wall St. Rank hold XYL as of Q2 2021.

  • Thompson Siegel & Walmsley reported no remaining Xylem position as of Q2 2021 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 6 Xylem shares in Q2 2021, an estimated $1K.
  • Thompson Siegel & Walmsley first reported a position in Xylem in Q2 2013 and held it in 6 quarters.
  • Thompson Siegel & Walmsley's Xylem position peaked at $1.17M in Q4 2013.
  • 773 funds tracked by Wall St. Rank held Xylem as of Q2 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2021, filed 9 Aug 2021.